Literature DB >> 16651882

The burden of radiation-induced central nervous system tumors: a single institution s experience.

B K Kleinschmidt-Demasters1, Jennifer S Kang, Kevin O Lillehei.   

Abstract

Radiation-induced tumors of the central and peripheral nervous systems are becoming a noticeable subset of tumors seen at referral institutions. This paper outlines a single institution s experience with 22 examples of secondary meningiomas, gliomas, and sarcomas that developed in adults. These tumors are being increasingly encountered by physicians, but the greatest burden is on the patients themselves, who not only experience the life-altering effects of the original tumor and the subsequent delayed cognitive effects of radiotherapy, but later develop a second intracranial neoplasm. We detail a particularly poignant example of a 34-year-old man who developed a high-grade sarcoma with rhabdomyosarcomatous and osteogenic elements. Local control was difficult over the next year, and he eventually developed cerebrospinal fluid dissemination and succumbed. Although radiation-induced neoplasm remain relatively infrequent numerically, each case reminds us of the need for new, less toxic, and more targeted therapies for brain neoplasms.

Entities:  

Mesh:

Year:  2006        PMID: 16651882     DOI: 10.1097/01.jnen.0000205146.62081.29

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.

Authors:  Hemant Sarin
Journal:  Mol Clin Oncol       Date:  2015-12-16

2.  Treatment strategies for initially disseminated intracranial germinomas: experiences at a single institute.

Authors:  Yi-Wei Chen; Pin-I Huang; Yu-Wen Hu; Donald Ming-Tak Ho; Kai-Ping Chang; Wan-Yuo Guo; Feng-Chi Chang; Yi-Yen Lee; Cheng-Ying Shiau; Tai-Tong Wong; Sang-Hue Yen
Journal:  Childs Nerv Syst       Date:  2012-01-13       Impact factor: 1.475

3.  Management of petroclival meningiomas: a review of the development of current therapy.

Authors:  Adrian J Maurer; Sam Safavi-Abbasi; Ahmed A Cheema; Chad A Glenn; Michael E Sughrue
Journal:  J Neurol Surg B Skull Base       Date:  2014-05-27

4.  Anaplastic PXA in adults: case series with clinicopathologic and molecular features.

Authors:  Yao Schmidt; B K Kleinschmidt-DeMasters; Dara L Aisner; Kevin O Lillehei; Denise Damek
Journal:  J Neurooncol       Date:  2012-10-25       Impact factor: 4.130

Review 5.  Risk and survival outcomes of radiation-induced CNS tumors.

Authors:  Jessica W Lee; A Gabriella Wernicke
Journal:  J Neurooncol       Date:  2016-05-21       Impact factor: 4.130

6.  Prognostic factors for long-term survival after glioblastoma.

Authors:  Mohammad Sami Walid
Journal:  Perm J       Date:  2008

7.  Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.

Authors:  Hunter C Gits; Maia Anderson; Stefanie Stallard; Drew Pratt; Becky Zon; Christopher Howell; Chandan Kumar-Sinha; Pankaj Vats; Katayoon Kasaian; Daniel Polan; Martha Matuszak; Daniel E Spratt; Marcia Leonard; Tingting Qin; Lili Zhao; James Leach; Brooklyn Chaney; Nancy Yanez Escorza; Jacob Hendershot; Blaise Jones; Christine Fuller; Sarah Leary; Ute Bartels; Eric Bouffet; Torunn I Yock; Patricia Robertson; Rajen Mody; Sriram Venneti; Arul M Chinnaiyan; Maryam Fouladi; Nicholas G Gottardo; Carl Koschmann
Journal:  Acta Neuropathol Commun       Date:  2018-07-26       Impact factor: 7.801

8.  Unique Case Report of a Meningeal Sarcoma Arising during Ongoing Treatment for Progressing Intraparenchymal Glioma.

Authors:  Richard A Peterson; Bhavani Kashyap; Pamala A Pawloski; Anna C Forsberg; Leah R Hanson
Journal:  Case Rep Oncol Med       Date:  2019-11-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.